123 related articles for article (PubMed ID: 37748565)
21. Sex-dependent regulation of estrogen receptor beta in human colorectal cancer tissue and its relationship with clock genes and VEGF-A expression.
Herichova I; Reis R; Hasakova K; Vician M; Zeman M
Physiol Res; 2019 Dec; 68(Suppl 3):S297-S305. PubMed ID: 31928047
[TBL] [Abstract][Full Text] [Related]
22. Association of the oestrogen receptor beta with hormone status and prognosis in a cohort of female patients with colorectal cancer.
Topi G; Ehrnström R; Jirström K; Palmquist I; Lydrup ML; Sjölander A
Eur J Cancer; 2017 Sep; 83():279-289. PubMed ID: 28763692
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways.
Zhou M; Sareddy GR; Li M; Liu J; Luo Y; Venkata PP; Viswanadhapalli S; Tekmal RR; Brenner A; Vadlamudi RK
Sci Rep; 2019 Apr; 9(1):6124. PubMed ID: 30992459
[TBL] [Abstract][Full Text] [Related]
24. Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity.
Ibrahim A; Hugerth LW; Hases L; Saxena A; Seifert M; Thomas Q; Gustafsson JÅ; Engstrand L; Williams C
Int J Cancer; 2019 Jun; 144(12):3086-3098. PubMed ID: 30515752
[TBL] [Abstract][Full Text] [Related]
25. ERβ-dependent neuroglobin up-regulation impairs 17β-estradiol-induced apoptosis in DLD-1 colon cancer cells upon oxidative stress injury.
Fiocchetti M; Camilli G; Acconcia F; Leone S; Ascenzi P; Marino M
J Steroid Biochem Mol Biol; 2015 May; 149():128-37. PubMed ID: 25683270
[TBL] [Abstract][Full Text] [Related]
26. Calycosin induces apoptosis in colorectal cancer cells, through modulating the ERβ/MiR-95 and IGF-1R, PI3K/Akt signaling pathways.
Zhao X; Li X; Ren Q; Tian J; Chen J
Gene; 2016 Oct; 591(1):123-128. PubMed ID: 27393650
[TBL] [Abstract][Full Text] [Related]
27. Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.
Docquier A; Garcia A; Savatier J; Boulahtouf A; Bonnet S; Bellet V; Busson M; Margeat E; Jalaguier S; Royer C; Balaguer P; Cavaillès V
Mol Endocrinol; 2013 Sep; 27(9):1429-41. PubMed ID: 23885094
[TBL] [Abstract][Full Text] [Related]
28. Calycosin suppresses colorectal cancer progression by targeting ERβ, upregulating PTEN, and inhibiting PI3K/Akt signal pathway.
Zhu L; Liu S; Liao YF; Sheng YM; He JC; Cai ZX; Man Q; Wu YY
Cell Biol Int; 2022 Sep; 46(9):1367-1377. PubMed ID: 35842774
[TBL] [Abstract][Full Text] [Related]
29. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor β potentiates the antiproliferative effect of raloxifene and affects the cell migration and invasion in HCT-116 colon cancer cells.
Tu Z; Ma Y; Tian J; Li H; Akers W; Achilefu S; Gu Y
J Cancer Res Clin Oncol; 2012 Jul; 138(7):1091-103. PubMed ID: 22398780
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of estrogen receptor β increases proliferation and affects the transcriptome of endometrial adenocarcinoma cells.
Treeck O; Diepolder E; Skrzypczak M; Schüler-Toprak S; Ortmann O
BMC Cancer; 2019 Jul; 19(1):745. PubMed ID: 31357971
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity.
Lindberg K; Helguero LA; Omoto Y; Gustafsson JÅ; Haldosén LA
Breast Cancer Res; 2011 Apr; 13(2):R43. PubMed ID: 21492444
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective action of raloxifene against hypoxia-induced damage in mouse hippocampal cells depends on ERα but not ERβ or GPR30 signalling.
Rzemieniec J; Litwa E; Wnuk A; Lason W; Gołas A; Krzeptowski W; Kajta M
J Steroid Biochem Mol Biol; 2015 Feb; 146():26-37. PubMed ID: 24846829
[TBL] [Abstract][Full Text] [Related]
34. Expression of estrogen receptor beta in human colorectal cancer.
Xie LQ; Yu JP; Luo HS
World J Gastroenterol; 2004 Jan; 10(2):214-7. PubMed ID: 14716825
[TBL] [Abstract][Full Text] [Related]
35. Expression of ERalpha, ERbeta and co-regulator PELP1/MNAR in colorectal cancer: prognostic significance and clinicopathologic correlations.
Grivas PD; Tzelepi V; Sotiropoulou-Bonikou G; Kefalopoulou Z; Papavassiliou AG; Kalofonos H
Cell Oncol; 2009; 31(3):235-47. PubMed ID: 19478391
[TBL] [Abstract][Full Text] [Related]
36. Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer.
Pérez-Ruiz E; Rueda A; Pérez L; Rivas-Ruiz F; Torres E; de Luque V; Álvarez M; Sevilla I; Redondo M; Padilla-Ruiz M; Alba E; Alonso L
Pathol Oncol Res; 2018 Oct; 24(4):871-879. PubMed ID: 28889324
[TBL] [Abstract][Full Text] [Related]
37. A novel shift in estrogen receptor expression occurs as estradiol suppresses inflammation-associated colon tumor formation.
Armstrong CM; Billimek AR; Allred KF; Sturino JM; Weeks BR; Allred CD
Endocr Relat Cancer; 2013 Aug; 20(4):515-25. PubMed ID: 23702470
[TBL] [Abstract][Full Text] [Related]
38. Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.
Yu CP; Ho JY; Huang YT; Cha TL; Sun GH; Yu DS; Chang FW; Chen SP; Hsu RJ
PLoS One; 2013; 8(2):e56667. PubMed ID: 23460808
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor beta as target for colorectal cancer prevention.
Williams C; DiLeo A; Niv Y; Gustafsson JÅ
Cancer Lett; 2016 Mar; 372(1):48-56. PubMed ID: 26708506
[TBL] [Abstract][Full Text] [Related]
40. Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen.
Wu X; Subramaniam M; Grygo SB; Sun Z; Negron V; Lingle WL; Goetz MP; Ingle JN; Spelsberg TC; Hawse JR
Breast Cancer Res; 2011 Mar; 13(2):R27. PubMed ID: 21392396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
